This is the same pathway through which SSRIs reduce libido
BPC-157 works on the physical plumbingthe vascular and nerve tissuewhile a peptide like [PT-141]( works on the central nervous system to increase libido
Third, constipation and diarrhea, which represent opposing effects on bowel function, both increased with orforglipron treatment, reflecting the complex effects of GLP-1 receptor activation on gut motility, water absorption, and intestinal secretion
The Localized Argument: On the other side, some researchers believe that while BPC-157 does have systemic effects, administering it as close as possible to the target tissue could provide a higher concentration of the peptide where it's needed most
People following GLP-1based weight-management programs may be using different medications, including commonly known options such as Ozempic, Wegovy, Zepbound, or Mounjaro